Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

ConditionEsophagectomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorNorthwestern University

About this trial

The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure. Clinical (or health) outcomes measure the effect of the procedure on your overall health status. During this procedure, the surgeon will remove all or part of your esophagus. We want to identify patients who will have this procedure. We will look at data elements before, during, and after your procedure to understand the impact of this surgery on your post-operative clinical outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients (18 years or older)

Patients undergoing elective esophagectomy for any indication

Patients who have already had an elective esophagectomy for any indication

Patients with consent providing capacity

Disqualifiers

Patients undergoing emergent esophagectomy

Adults unable to consent

Individuals who are not yet adults (infants, children, teenagers)

Pregnant women

Trial population

Participants will be identified in the Thoracic Surgery clinic or in the inpatient setting based on the surgeon's expertise who need to undergo an elective esophagectomy procedure.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Esophagectomy

    Procedure/Surgery

    Esophagectomy is a complex surgical procedure performed to treat various esophageal disorders. The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of Participants with Anastomotic Leak

Postoperative Complication

Time frame
During first 3 months postop
2

Number of Participants with Esophageal Stricture

Postoperative Complication

Time frame
During first 3 months postop
3

Number of Participants with Pneumonia

Postoperative Complication

Time frame
During first 3 months postop
4

Number of Participants Requiring Ventilation >48 Hours

Postoperative Complication

Time frame
During first 3 months postop

Secondary outcomes

1

Operative Time of Surgery

Length of Surgery

Time frame
Intraoperative
2

Rates of Blood Loss

Did the Participant Lose Any Blood During the Surgery

Time frame
Intraoperative
3

Number of Participants with Conversion Rates to Open Esophagectomy

Time frame
Intraoperative
4

Number of Participants with Lymph nodes in the Final Specimen

Pathological Variables

Time frame
Intraoperative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.